Christian E. Palavecino earned his Medical Technologist degree at the Universidad Austral de Chile in 2001. He then earned his M.Sc. and Ph.D. in Microbiology and Molecular Biology from the Universidad Austral de Chile. Dr. Palavecino was awarded an Alban office grant to develop his Ph.D. thesis at the Queen Mary University of London to investigate the molecular basis of Mycobacterium-host interactions. After his Ph.D. degree, he was a postdoctoral fellow at the School of Biological Sciences at the Pontificia Universidad Católica de Chile, focusing his research on vaccine development to prevent human metapneumovirus infection. He is currently an assistant professor at the Facultad de Ciencias de la Salud at the Universidad Central de Chile, working to develop complementary antimicrobial therapy against multidrug-resistant bacteria. His research focuses on developing and evaluating photosensitizing molecules used in photodynamic therapy to inhibit bacterial growth.